For instance, Daren et al. [34] demonstrated that dysregulation of the UBE3A interferes with the transcriptional regulatory network of the melanocortin-1 receptor (MC1R), ultimately leading to the hypopigmentation phenotype observed in patients with Angelman syndrome (AS). This evidence concerns the gene UBE3A and Angelman syndrome.